Brentuximab vedotin

AbMole BioScience

Brentuximab vedotin

9

914088-09-8

Chemical

Research Use Only

Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). Brentuximab vedotin inhibits CD30-positive cells with an IC50 of 2.5 ng/mL. Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.

Please store the product under the recommended conditions in the Certificate of Analysis.

12352200